Page last updated: 2024-09-05

sb 203580 and lhrh, his(5)-trp(7)-tyr(8)-

sb 203580 has been researched along with lhrh, his(5)-trp(7)-tyr(8)- in 1 studies

Compound Research Comparison

Studies (sb 203580)	Trials (sb 203580)	Recent Studies (post-2010) (sb 203580)	Studies (lhrh, his(5)-trp(7)-tyr(8)-)	Trials (lhrh, his(5)-trp(7)-tyr(8)-)	Recent Studies (post-2010) (lhrh, his(5)-trp(7)-tyr(8)-)
3,489	4	1,137	183	0	29

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Auersperg, N; Choi, KC; Chou, CS; Kim, KY; Leung, PC; Park, SH	1

Other Studies

1 other study(ies) available for sb 203580 and lhrh, his(5)-trp(7)-tyr(8)-

Article	Year
Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells. The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:6 Topics: Adenocarcinoma; Apoptosis; Cell Division; Cell Line, Tumor; Enzyme Inhibitors; Female; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Transcription Factor AP-1	2004

Article

Year

Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells.

The Journal of clinical endocrinology and metabolism, 2004, Volume: 89, Issue:6

Topics: Adenocarcinoma; Apoptosis; Cell Division; Cell Line, Tumor; Enzyme Inhibitors; Female; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Mitogen-Activated Protein Kinases; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Pyridines; Signal Transduction; Transcription Factor AP-1

2004